pifithrin has been researched along with Diabetes Mellitus in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshino, A | 1 |
| Ariyoshi, M | 1 |
| Okawa, Y | 1 |
| Kaimoto, S | 1 |
| Uchihashi, M | 1 |
| Fukai, K | 1 |
| Iwai-Kanai, E | 1 |
| Ikeda, K | 1 |
| Ueyama, T | 1 |
| Ogata, T | 1 |
| Matoba, S | 1 |
1 other study available for pifithrin and Diabetes Mellitus
| Article | Year |
|---|---|
Inhibition of p53 preserves Parkin-mediated mitophagy and pancreatic β-cell function in diabetes.
Topics: Animals; Benzothiazoles; Cell Line; Diabetes Mellitus; Endoplasmic Reticulum Stress; Flow Cytometry; | 2014 |